Por qué asistir
En este tiempo incierto y sin precedentes, debido al aumento de las infecciones por Covid-19, existe ahora una desesperada necesidad de mayor colaboración y comunicación en el sector de la salud animal. Las asociaciones estratégicas son vitales para brindar nuevas soluciones a la “Siguiente normalidad” para la industria.
Para América Latina, la situación está evolucionando. La región es una de las geografías más importantes para la producción de proteína animal, y es el tercer mercado global más grande para la salud animal. Frente al desafío mundial de alimentar a otros 2000 millones de personas para el 2050 como una prioridad de primer orden,
América Latina seguirá teniendo que aumentar sus volúmenes de producción anual en un 70 %, y reducir en gran medida el número de animales que actualmente se pierden por muerte y enfermedad, que hoy en día se estima en más del 20 %. La región también es el tercer mercado global más grande en cuidado de mascotas, y el Brasil es el hogar de más de 58 millones de perros y 27 millones de gatos. Los dueños de mascotas brasileños reservan un presupuesto aparte para sus animales de compañía y los tratan como miembros de la familia. Esto forma parte de una tendencia mundial de humanización que afecta de manera significativa a la industria y crea nuevas oportunidades de negocio, que continúan incluso en esta crisis.
En Kisaco Research, estamos comprometidos con brindarle a la comunidad de salud animal una plataforma donde podamos juntarnos, seguir creando conexiones vitales y estratégicas, e impulsar la firma de tratos por medio de reuniones de asociación virtuales. Entendemos que esta constituirá una nueva experiencia para muchos de ustedes en todo el mundo; pero la operación virtual es ahora la nueva normalidad en los negocios, y esperamos ansiosamente trabajar con ustedes para hacer de esta una experiencia verdaderamente efectiva.
¿Quiénes asisten?
ORADORES Y COLABORADORES
Carlos Alberto Kuada
Matias de Juan
Klaus Hellmann
Flávia De Marco Almeida
Luiz Luccas
Delair Angelo Bolis
Luiz Xavier Royas
Marcio Waldman
Felipe Cunha
Felipe Diz
Kleber Gomes
Byron Silva
PROFILE:
- Veterinary with expertise for over 35 years in veterinary products segment working for local and global players. Previous experience in several areas of veterinary industry: vaccine production, QC, R&D, product manager, technical assistance and regulatory affairs.
- Support for technical and regulatory affairs for new and existing business.
- Support for development of new businesses in Brazil for global players.
Maria Aparecida Melo Luspa, MSc.
Gustavo Osorio
Gustavo Osorio is a Mexican Veterinarian who started his successful career in the Animal Health Industry as sales representative for companion animal products with Pfizer Animal Health, where he gained commercial experience working with distributors and third party sales forces.
During his tenure in Pfizer Animal Health, Gustavo held different position of increased responsibility. He worked as Technical Manager for Companion Animal being responsible for technical trainings for the team as well as speaker in different events. He was promoted to Sales Force Manager, working in a sales efficiency project while starting his incursion in marketing, this movement allowed him to move to the Marketing Manager position.
In 2006, Gustavo joined Bayer Animal Health as Marketing Manager for Companion Animals. During his 8 year tenure, he contributed to the evolution of the business unit by introducing new lines of products while managing the growth of the companion animals portfolio.
From 2014 to 2018, Gustavo was Influencer Marketing Manager for Eukanuba at Mars. This position allowed him to better understand the motivations and habits of pet owners as well as learn from the pet food industry and gain a new set of skills oriented at the commercial models applied in this segment.
Since 2018, Gustavo is the Commercial Manager for Mexico, Central America and the Caribbean at Dechra Brovel, the Mexican subsidiary of Dechra. He is focused on the transformation of the company structure from a family owned company to an international corporation, successfully launching specialized products such as Vetoryl and Zycortal while maintaining the growth of the generic products business. He is also developing and strengthening his team to address future challenges.
Kieran Gartlan
Angélica Patarroyo Vargas
Arthur Gabriel da Silva
Bruna Nunes Marsiglio Sarout
Carla Berl
Ricardo Nassar
Ricardo Nassar has graduated in Business Administration by FAAP, an important University in Brazil. He is one of the co-founder at Cobasi – o shopping do seu animal since 1885.
Together with his brothers, has created the concept of big pet shop in Brazil and has turned Cobasi into a reference in the Brazilian pet market. Cobasi is currently sales leader, with more 100 stores and e-commerce.
Kristin Bloink
Kristin Bloink manages all internal discovery efforts and all external technology evaluations and subsequent portfolio entries for R&D. She has 26 years of accomplishments in human clinical trials, animal drug discovery and development, translational model development and execution, and human and veterinary clinical medical delivery in the private as well as the military sector. She joined Novartis Animal Health in 2007 and integrated into Elanco Animal Health in 2015.
Flavia Reis
Mauricio Salvador
Eduardo Carlos de Gosztonyi Abecia
Clóvis De Oliveira
Carla Freitas
Socio titular
Elanco
Website: http://www.elanco.com
Elanco (NYSE: ELAN) is a global animal health company that develops products and knowledge services to prevent and treat disease in farm animals and pets in more than 90 countries. With a 65-year heritage, we rigorously innovate to improve the health of animals and benefit our customers, while fostering an inclusive, cause-driven culture for more than 5,800 employees. At Elanco, we’re driven by our vision of food and companionship enriching life - all to advance the health of animals, people and the planet. Learn more at www.elanco.com.
Socios adjuntos
MSD Animal Health
For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, is the global animal health business unit of MSD. Through its commitment to the Science of Healthier Animals®, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of digitally connected identification, traceability and monitoring products. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.msd-animal-health.com/ or connect with us on LinkedIn and Twitter.
Zoetis
Website: http://www.zoetis.com
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2019, the company generated annual revenue of $6.3 billion with approximately 10,600 employees.
For more information, visit www.zoetis.com.
IDEXX
Website: http://www.idexx.com
IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency, and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry, and testing for the quality and safety of water and milk. Headquartered in Maine, IDEXX employs more than 8,000 people and offers products to customers in over 175 countries.
Our purpose is to be a great company that creates exceptional long-term value for our customers, employees, and shareholders by enhancing the health and well-being of pets, people, and livestock.
For more information about IDEXX, visit: www.idexx.com
Agenda
Puede descargar nuestra agenda aquí.
Solo debe completar este formulario y le enviaremos una versión en PDF de inmediato. Necesitamos algunos datos para saber dónde enviar el archivo y cómo enviarle nuestra dirección de correo electrónico. Tenga en cuenta que también habrá un enlace al PDF disponible de inmediato una vez que envíe este formulario.
Agenda
Junta de Asesoramiento Global
Author:
Clinton Lewis
Author:
Linda Rhodes
Dr. Rhodes has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.
Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine. She has an extensive background in physiology, veterinary medicine, and molecular biology. As a senior research fellow at Merck Research Laboratories for 10 years, she led pre-clinical biology evaluation of several marketed human drugs. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. She worked for Merial Ltd. as director of development projects, leading project teams developing novel compounds for a variety of indications and headed new technology assessment, leading the evaluation of licensing opportunities. In April 2001, she formed AlcheraBio, a consulting, marketing, communications and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies, with clients in the US, European Union, Canada and Australia. AlcheraBio was acquired in 2008 by Argenta, and in 2011, Dr. Rhodes accepted a position as CEO of Aratana Therapeutics, a company developing innovative new medicines for dogs and cats, and subsequently, when the company became public (PETX) served as its Chief Scientific Officer. During her tenure, development was completed on three new pet therapeutics: two new molecules with novel mechanisms of actions were approved by the FDA, and a third drug had FDA registration completed and was approved in August, 2016. She is currently retired and an independent consultant. She is a member of the Board of Directors of ImmuCell (NASDAQ: ICCC) and the Alliance for Contraception in Dogs and Cats, serves on the Scientific Advisory Board of the Found Animals Foundation. She is an adjunct faculty member in the Graduate Animal Science program at Rutgers University.
Author:
Aaron Schacht
Author:
Dr. James Lloyd
Paquetes de conferencia
¿Envía a su equipo? ¡Hay descuentos para grupos disponibles!
Solo se aplica para tarifas de mercado primario, proveedores de servicios e industrias. No disponible para tarifas para académicos o empresas emergentes.
Reserve para un equipo de más de 3 personas - Ahorre un 10 % adicional
Reserve para un equipo de más de 5 personas - Ahorre un 15 % adicional
Si desea inscribir a un equipo de 3 integrantes o más, envíe un correo electrónico a [email protected] para obtener el código del cupón de descuento antes de la inscripción.
TENGA EN CUENTA LO SIGUIENTE: Los descuentos no se pueden combinar con los precios para reserva anticipada ni ningún otro descuento u oferta. Si tiene preguntas sobre su inscripción, comuníquese con nosotros al +44 (0)20 3696 2920
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Conviértase en patrocinador
Kisaco Research ofrece una única y esencial plataforma en la que los ejecutivos del sector pueden hacer contactos, conectarse y aprender unos de otros, además de conocer socios potenciales.
Lejos de la típica experiencia de exposición de bienvenida, usted (como patrocinador o expositor) estará posicionado como socio del evento con un enfoque en los beneficios de su producto y marca, en lugar de ser solo un nombre en una lista de expositores.CONSÚLTENOS SOBRE LOS DIFERENTES TIPOS DE PARTICIPACIÓN
Comuníquese con nuestro equipo para obtener más información sobre cada paquete escribiendo a [email protected] o llamando al +44 (0)20 3696 2920
Asociaciones de prensa
Ya sea que se trate de una asociación, embajada, organismo industrial o publicación, podemos ofrecer una asociación de marketing que se adapte a sus necesidades. Como socio de medios podemos:
- Promover su organización como socio del evento en todos los materiales de la conferencia, que incluyen sitio web, folletos, correos electrónicos y programa en el lugar
- Ofrecerles a sus miembros o lectores un descuento en la tarifa de inscripción a Animal Health Investment Europe
- Ofrecer un pase de prensa gratuito para asistir
- Distribuir material promocional en la conferencia
Si es periodista acreditado del sector o miembro de prensa y desea concretar una entrevista con un orador o hablar sobre el evento, póngase en contacto con:
Sarah Rowlands
T: +44 (0)203 696 2920
E: sarah.rowlands[@]kisacoresearch.com
